↓ Skip to main content

Ethical issues in stem cell research and therapy

Overview of attention for article published in Stem Cell Research & Therapy, July 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
3 X users
patent
1 patent
wikipedia
2 Wikipedia pages
googleplus
1 Google+ user

Citations

dimensions_citation
165 Dimensions

Readers on

mendeley
486 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Ethical issues in stem cell research and therapy
Published in
Stem Cell Research & Therapy, July 2014
DOI 10.1186/scrt474
Pubmed ID
Authors

Nancy MP King, Jacob Perrin

Abstract

Rapid progress in biotechnology has introduced a host of pressing ethical and policy issues pertaining to stem cell research. In this review, we provide an overview of the most significant issues with which the stem cell research community should be familiar. We draw on a sample of the bioethics and scientific literatures to address issues that are specific to stem cell research and therapy, as well as issues that are important for stem cell research and therapy but also for translational research in related fields, and issues that apply to all clinical research and therapy. Although debate about the moral status of the embryo in human embryonic stem cell research continues to have relevance, the discovery of other highly multipotent stem cell types and alternative methods of isolating and creating highly multipotent stem cells has raised new questions and concerns. Induced pluripotent stem cells hold great promise, but care is needed to ensure their safety in translational clinical trials, despite the temptation to move quickly from bench to bedside. A variety of highly multipotent stem cells - such as mesenchymal stem/stromal cells and stem cells derived from amniotic fluid, umbilical cord blood, adipose tissue, or urine - present the opportunity for widespread biobanking and increased access. With these increased opportunities, however, come pressing policy issues of consent, control, and justice. The imperatives to minimize risks of harm, obtain informed consent, reduce the likelihood of the therapeutic misconception, and facilitate sound translation from bench to bedside are not unique to stem cell research; their application to stem cell research and therapy nonetheless merits particular attention. Because stem cell research is both scientifically promising and ethically challenging, both the application of existing ethical frameworks and careful consideration of new ethical implications are necessary as this broad and diverse field moves forward.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 486 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Chile 1 <1%
Argentina 1 <1%
Unknown 484 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 136 28%
Student > Master 63 13%
Student > Ph. D. Student 47 10%
Researcher 30 6%
Student > Doctoral Student 21 4%
Other 47 10%
Unknown 142 29%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 99 20%
Medicine and Dentistry 57 12%
Agricultural and Biological Sciences 55 11%
Engineering 26 5%
Neuroscience 15 3%
Other 77 16%
Unknown 157 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 February 2023.
All research outputs
#1,332,605
of 23,257,423 outputs
Outputs from Stem Cell Research & Therapy
#60
of 2,449 outputs
Outputs of similar age
#13,956
of 226,811 outputs
Outputs of similar age from Stem Cell Research & Therapy
#1
of 22 outputs
Altmetric has tracked 23,257,423 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,449 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 226,811 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.